“Towards embedding genomics in T1D” RFA open

“Towards embedding genomics in T1D” RFA open


JDRF is dedicated to creating a world without type 1 diabetes (T1D). Throughout the world, we lead the fight against T1D by funding research to find cures and improve lives for those living with the condition.

Through the T1D Clinical Research Network (T1DCRN) and other key programs, JDRF Australia has built a track record of successful implementation of initiatives aimed at accelerating the pace of translation and embedding outcomes into clinical care.

To understand the pathway towards more personalised care for T1D patients, from 2021-2023, JDRF Australia embarked upon a four-phased consultation process centred around an expert panel, concluding in the release of a White Paper titled: “Towards precision medicine for Type 1 Diabetes in Australia”, which will be available through JDRF Australia’s website in July 2023. The white paper presents specific research direction recommendations and priorities that emerged from the consultation process, and outlines JDRF Australia’s vision for precision medicine in T1D in Australia.

To be able to realise this vision, we need to tap into existing expertise, leading technology and advanced national infrastructure and align and connect with key global research efforts to deliver a paradigm shift in T1D research. This is the foundation for the ‘Towards embedding genomics in T1D’ Request for Application.


Towards embedding genomics in T1D Request for Application:  

 The purpose of the Request for Applications (RFA) “Towards embedding genomics in T1D” is to support a capacity building initiative in T1D genomics by harnessing these resources, increasing workforce genomics skill set and capability and broadening the scope of genomic medicine in Australia to address T1D challenges. 


The objectives of the RFA are:  

  • To enable the expansion and acceleration of discovery of current efforts in T1D and support novel genomics research approaches, drawing from established expertise outside the T1D field. 
  • To promote innovation in identifying clinically relevant cohorts and enable the conduct of meaningful research in functional genomics.  
  • To support the T1D genomic research community in establishing and fostering national and international collaborations with researchers outside the field of T1D.



Researchers, clinicians, geneticists, and bioinformaticians with expertise in T1D and non-T1D functional genomics, inclusive of epigenomics, transcriptomics, proteomics, metabolomics, and pharmacogenomics, are eligible to apply. For more information on eligibility go to the full RFA.    


How to apply: 

Applications are to be submitted online using the online grants management system RMS360, by 1 August 2023. For instructions on how to use the RMS360, please click here. 





Request for Applications 


Key Dates: 

  • Applications open: 15 June 2023
  • LOI Deadline: 1 August 2023
  • Invitation to full proposals: 12 September 2023
  • Full proposal deadline: 24 October 2023


Contact personnel:  

For enquiries on the RFA and eligibility contact:  


Dorota Pawlak, PhD

Chief Scientific Officer   

JDRF Australia   

E: dpawlak@jdrf.org.au  


Miranda Xhilaga, PhD

Scientific Program Manager   

JDRF Australia  

P:(02) 8364 0250; 0413 181 613  / E: mxhilaga@jdrf.org.au